Validation of a Self-questionnaire in French on the Use of the Upper Limbs in Patients With Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Interventions
- Other: Validation of AMSQ questionnaire
- Registration Number
- NCT03655093
- Lead Sponsor
- Rennes University Hospital
- Brief Summary
Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system that causes disability in young adults. This disability can take many forms depending on the neurological systems affected: disability walking, cognitive impairment or disability in the upper limbs. The development of validated measurement tools for these different disabilities is essential for the follow-up of patients in clinical routine and for the evaluation of new therapies.
- Detailed Description
A specific self-questionnaire for patients with MS has recently been developed and validated in English and Dutch: "The Arm Function in Multiple Sclerosis Questionnaire (AMSQ)". The questionnaire groups 31 items and was created from questionnaires developed for other pathologies. The Dutch team that developed this questionnaire combines biostatisticians and neurologists, experts in the development and validation of disability measurement tools.
This study aims to validate the French version of AMSQ questionnaire. This study is carried out in collaboration with the Amsterdam team, which has carried out the methodology and will conduct the statistical analysis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- Patient with MS according to the diagnostic criteria of 2010
- Age ≥18 years
- Patients seen in consultation at the SEP reference center in Rennes
- Other neurological or rheumatological pathology hindering the use of the upper limbs
- Inability to understand
- Minors
- Major persons subject to legal protection (legal safeguards, guardianship)
- Persons deprived of their liberty
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with multiple sclerosis Validation of AMSQ questionnaire Patients with MS according to the diagnostic criteria of 2010 Validation of AMSQ questionnaire
- Primary Outcome Measures
Name Time Method Validate the French version of the AMSQ self-questionnaire in a population of MS patients At inclusion Evaluate item fit of the French version of the AMSQ using the graded response model, developed by Samejima (cf. reference)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rennes University Hospital
🇫🇷Rennes, France